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Abstract 
Cavernous hemangiomas are the most common benign tumors of the liver. They can 
reach enormous sizes and cause various complications. Kasabach-Merritt syndrome is a 
rare but serious complication characterized by consumptive coagulopathy caused by the 
hemangioma; mortality rate ranges between 10 and 37%. More than 80% of cases occur 
within the first year of life. Goals of the treatment are to control the coagulopathy and 
thrombocytopenia as well as to eradicate the hemangioma. Different nonsurgical 
treatment regimens are performed, including systemic corticosteroids, irradiation and 
various chemicals. Surgery should be limited to symptomatic or complicated cases. 
Although difficult, resection of the tumor is usually curative. Here we present a 
44-year-old woman with giant hepatic hemangioma causing Kasabach-Merritt syndrome 
managed by enucleation. 
 
Introduction 
Cavernous hemangiomas are the most common benign tumors of the liver. Giant 
cavernous hemangiomas are those larger than 4 cm in diameter and can reach enormous 
sizes. The diagnosis should not be augmented by biopsy because of the risk of 
hemorrhage [1]. Enucleation is an underused procedure that if carefully performed allows 
resection of giant hemangiomas with reduced blood loss and preservation of virtually all 
normal hepatic parenchyma [2]. Kasabach-Merritt syndrome (KMS) is a consumptive 
coagulopathy caused by hemangioma. The mortality rate of this syndrome is 10–37% [3].  
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Here we present a 44-year-old woman with giant hepatic hemangioma causing KMS 
managed by enucleation. 
Case Report 
A 44-year-old female presented with pain persisting for two months on the right upper abdominal 
quadrant. An abdominal ultrasound performed one month earlier showed a mass in the liver. She had 
been examined by a gynecologist two years before due to dysmenorrhea and her clotting tests revealed 
that she had a prolonged clotting time but no cause was found. She did not use any medication 
including oral contraceptives. Physical examination was normal. Complete blood count showed that she 
had trombocytopenia (platelet count 20,000/mm
3). The international normalized ratio was prolonged 
(table 1) and Quick test time was shortened. Abdominal ultrasound and contrast computerized 
tomography revealed two different masses on the liver. One of the masses was a 46 × 27 mm 
hypovascular inhomogeneous mass with centrally cystic degeneration on segment 2. The other mass 
was a 218 × 158 × 128 mm giant mass on the right lobe with the same characteristics (fig. 1, fig. 2). 
Laparotomy revealed multiple numerous microhemangiomas on the remaining liver. The major 
hemangioma was totally enuclated (fig. 3), but the lesser one was located on the middle of the left lobe 
and could damage the remaining liver tissue and so was not suitable for excision. The major 
hemangioma weighed 2,800 g and measured 25 × 19 × 9 cm. The postoperative course was uneventful. 
Platelet count was normal on postoperative day 3. Pathology was consistent with cavernous 
hemangioma (fig. 4). The 6-month control visit was uneventful. 
Discussion 
Cavernous hemangiomas are the most frequent type of benign liver tumor mostly 
discovered unexpectedly, either when patients undergo routine examination for 
nonspecific abdominal complaints or during laparotomy [4]. KMS is a rare but serious 
complication defined by a huge hemangioma
 with thrombocytopenia and consumption 
coagulopathy due to
 endothelial defects within the hemangioma. More than 80% of cases 
occur within the first year of life [5]. The etiology and malignant transformation is 
unknown and the typical patient is an infant, often male [6]. Mostly they remain 
asymptomatic and are discovered incidentally. Rarely a large hemangioma may cause 
right upper quadrant pain, but the potential for rupture is negligible and does not in itself 
constitute an indication for resection [7, 8]. The hematologic features of KMS and those 
of chronic coagulopathy seen with other vascular malformations can be similar, which 
makes KMS difficult to distinguish [9]. 
In the diagnostic process, these lesions must first be distinguished from hepatic 
malignancies. The widespread use of ultrasound and computed tomography scanning has 
made the occasional finding of a ‘nonhomogeneous area’ more common. Magnetic 
resonance imaging and computed tomography reveal a vascular enhancing mass which is 
difficult to differentiate from a vascular malformation [6]. Magnetic resonance imaging 
has reported sensitivities and specificities of up to 100% by gadolinium administration 
and is the preferred imaging technique for lesions smaller than 15 mm [10]. 
Treatment of this syndrome is often difficult, but resection of the tumor is usually 
curative. Since they are benign lesions, treatment is not imperative. There
 are two major 
treatment objectives, the control of the coagulopathy
 and thrombocytopenia as well as 
eradication of the hemangioma.
 Different treatment regimens are performed, including
 
systemic corticosteroids, irradiation,
 compression, embolization, antifibrinolytic agents, 
platelet aggregation inhibitors, interferon low dose heparin infusion, cryoprecipitate and 
aminocaproic acid [11–18]. Surgery should be limited to symptomatic or complicated 
cases. However, Velin et al. suggested that removal of localized hemangiomas in  
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nonfunctional areas is the most appropriate treatment for the patients with KMS [19]. 
There have been reports of ‘enucleation’ of the tumor [20]. We treated the patient by 
excising only one hemangioma because there was not sufficient residual liver tissue. 
Instead we cauterized the mass and still we treated KMS. Extremely rarely, hemangiomas 
of the liver require liver transplantation. Meguro et al. [6] and Klompmaker et al. [21] 
described one case of successful liver transplantation in an adult with giant hemangiomas 
and KMS. 
In conclusion, KMS is a complicated disease due to its mortality and difficult treatment 
modalities. Surgical treatment is still controversial but the only curative modality. 
 
 
 
Table 1. Clotting tests of the patient 
 One  week 
before 
surgery 
Preope- 
rative 
Postope- 
rative 
day 7 
Normal 
range 
Trombosit  .190  0.87  .251  .150–450 
Quick test  0.88  0.49  .109  0.70–130 
INR 1.07  1.53  0.95  0.90–1.25 
APTT  0.30  0.33  0.31 25.9–125.0 
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Fig. 1. Axial CT image of the hemangioma. 
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Fig. 2. Coronal CT image of the hemangioma. 
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Fig. 3. Surgically removed hemangioma. 
 
 
 
Fig. 4. Microscopic appearance of the hemangioma. 
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